Cytochrome P450 monooxygenases (P450s), which represent the major group of drug metabolizing enzymes in humans, also catalyze important synthetic and detoxicative reactions in insects, plants and many microbes. Flexibilities in their catalytic sites and membrane associations are thought to play central roles in substrate binding and catalytic specificity. To date, Escherichia coli expression strategies for structural analysis of eukaryotic membrane-bound P450s by X-ray crystallography have necessitated full or partial removal of their N-terminal signal anchor domain and, often, replacement of residues more peripherally associated with the membrane (such as the F-G loop region). Even with these modifications, investigations of P450 structural flexibility remain challenging with multiple single crystal conditions needed to identify spatial variations between substrate-free and different substrate-bound forms. To overcome these limitations, we have developed methods for the efficient expression of N-labeled His 4 CYP98A3 is expressed at yields of 2-4 mg per liter of minimal media without the necessity of generating side chain modifications or N-terminal deletions. Precipitated His 4 CYP98A3 generates high quality SSNMR spectra consistent with a homogeneous, folded protein. These data highlight the potential of these methodologies to contribute to the structural analysis of membranebound proteins.
Introduction
Cytochrome P450 monooxygenases (P450s) are ubiquitous and extensively reiterated in the genomes of higher organisms with humans containing 55 full-length genes, mosquitoes (Anopheles gambiae) containing 100 genes and plants (Arabidopsis thaliana, Oryza sativa) containing 245 and 334 genes, respectively, [http://drnelson.utmem.edu/CytochromeP450.html; http://p450. antibes.inra.fr; http://Arabidopsis-P450.biotec.uiuc.edu and Refs. [1] [2] [3] [4] ]. Mediating a range of hydroxylations, epoxidations, heteroatom dealkylations and aryl migrations, human P450s are best known for their roles in drug metabolism and steroid biosynthesis [5] , insect P450s are known for mediating the detoxification of plant toxins and insecticides [6, 7] and those in microorganisms are known for antibiotic syntheses and hydrocarbon hydroxylations [8] . Plant P450s mediate the detoxification of many environmentally damaging compounds, including herbicides, insecticides and pollutants, as well as the synthesis of defense compounds, including flavonoids, phenylpropanoids and terpenes, that protect them from their many predators and invasive pathogens [9] [10] [11] [12] .
CYP98A3 and three other P450s catalyze the difficult aromatic hydroxylations in the A. thaliana phenylpropanoid pathway leading to lignin, flavonoids and anthocyanins [13] . Although these P450s metabolize similar substrates, they are extremely substrate-specific with Arabidopsis CYP98A3 mediating the 3-hydroxylation of p-coumaroylshikimic acid and p-coumaroylquinic acid but not p-coumaraldehyde [14] and Triticum aestivum (wheat) CYP98A12 mediating these same hydroxylations as well as that of p-coumaroyltyramine [15] . Homology modeling and site-directed mutagenesis in CYP98A3 have revealed topological details important for substrate-protein interactions [Ref. [16] and S. Rupasinghe and M.A. Schuler, unpublished] . But, more detailed annotations of this protein's interactions with its substrates require structural analyses using physical methodologies (e.g., X-ray crystallography, NMR spectroscopy).
At present, 27 unique P450 structures are available in the NCBI Molecular Modeling Database (MMDB, http://www. ncbi.nlm.nih.gov/Structure/) or the Brookhaven Protein Database (PDB, http://www.rcsb.org). Comparisons between these structures indicate that the P450 fold is unique and the overall fold is quite conservative with a predominant α-helical α-domain that harbors the heme and a smaller β-sheet β-domain that contains the N-terminal anchor found in endoplasmic reticulum (ER)-localized eukaryotic P450s [17, 18] . The ability of some P450s, such as human CYP2D6 and CYP3A4, to metabolize multiple substrates [5] and the varying structures of human CYP2C9 bound to warfarin [19] and CYP3A4 bound to small (metyrapone and progesterone) versus large substrates (ketoconazole and erythromycin) [20, 21] indicate that P450s are structurally flexible [22, 23] . Studies with rabbit CYP2B4 and Sulfolobus solfataricus CYP119 have shown that the F-and G-helices and their intervening loop are flexible enough to undergo open-and-close motions upon substrate binding [24, 25] . Crystallographic experiments with Mycobacterium tuberculosis CYP51 with and without various substrates document flexibility in the region of the B'-and C-helices and their intervening loop as well as in the I-helix that are important for the induced fit binding of substrates [26, 27] .
The phospholipid component of the membrane has also been shown to affect catalysis and electron transfer between P450 and its reductase partner. Atomic force microscopy studies have shown the P450 protein sits upright on the lipid bilayer with its proximal and distal surfaces perpendicular to the lipid surface and regions close to the signal anchor domain dipped in the bilayer [28, 29] . In addition to this membrane anchor domain, regions close to substrate access channel pw1a (designated as in Wade et al. [30] ) and the F-G loop region appear to be embedded in the membrane.
High-level expression of these eukaryotic microsomal P450s in E. coli for crystallization studies has required deletion of the transmembrane signal anchor domain (SAD) from each of these proteins and, sometimes, substitution of hydrophobic residues in the F-G loop that associates with the lipid bilayer [31] . Because of this, investigations of P450 structural flexibilities by X-ray crystallography have remained challenging with many conditions needing to be tested for production of well-diffracting single crystals. In contrast to X-ray structure determinations, solid-state NMR spectroscopy (SSNMR) does not require single crystals to obtain high-resolution data. Several SSNMR studies over the past decade have demonstrated that if a protein is properly folded, hydrated and has microscopic order, high spectroscopic resolution with well-optimized instruments is attainable over a wide range of sample conditions [32] [33] [34] [35] [36] [37] . Consequently, NMR analysis is capable of assessing interactions between macromolecules and their ligands, defining structural details of membrane-embedded proteins [38] , monitoring molecular dynamics over a large range of time scales and studying the structures of weakly populated protein states that may play important roles in function [39] . Furthermore, NMR data can potentially be incorporated into homology modeling algorithms to refine computer models without completely relying on theoretical assessment tools.
Despite these advantages, the problems encountered in expressing membrane proteins in E. coli for structural studies are compounded by the requirement that proteins for NMR analysis be labeled in minimal media with one or more isotopes ( 13 C, 15 N, 2 H) derived from glucose, ammonium chloride and/or deuterium oxide [40] . While many soluble proteins have been effectively expressed under these stressed growth conditions, only short truncated fragments of one P450 (the N-terminal SAD and F-G loop of prostaglandin synthase) have been expressed in isotopic labeling media [41, 42] . In this paper, we have adapted the protocols of Marley et al. [40] for expression of isotopically labeled His 4 CYP98A3. Biochemical analysis of this protein indicates that it is structurally intact and suitable for SSNMR analysis. The initial SSNMR spectra reveal the high sensitivity of this preparation and display narrow (b 0.5 ppm) line widths. The number of signals observed is consistent with a single backbone conformation at most sites throughout the protein. These data demonstrate the ability of SSNMR to elucidate structural and mechanistic information of CYP98A3. In cases such as CYP98A3, when crystal structures are not yet available, SSNMR provides an impetus for improving molecular models and identifying key structural features that affect substrate specificity and membrane interactions. In other CYP monooxygenases where crystal structures are already available, SSNMR affords unique opportunities to test the structural variations in different contexts, including in native and mimetic membrane formulations, and to add insight at the level of chemical and conformational detail that are not typically derived from ∼2 Å crystal structures, including states of protonation and hybridization, hydrogen bonding, and functionally relevant dynamic events.
Materials and methods

Chemicals and reagents
Luria Broth (LB), Terrific Broth (TB) and M9 salts were made according to Sambrook et al. [43] . The recipe for 1 L of supplemented minimal growth media is shown in Table 1 
Construction and modification of CYP98A3 expression plasmid
The CYP98A3 cDNA [14] was cloned into the IPTG-inducible pET28a (Novagen, San Diego, CA) and pCWori [44] expression vectors between the NcoI-HindIII and NdeI-XbaI restriction sites, respectively, using PCR-based strategies. For optimal expression in E. coli, the 5′ primer directed against the translation start contained the initial methionine codon, an inserted alanine codon (residue 2) and E. coli optimized codons for the residues 2-11 in the wildtype CYP98A3 (renumbered residues 3-12 in the engineered CYP98A3). For purification purposes, the 3′ primer contained four histidine codons (His 4 -tag) downstream from the C-terminal amino acid. The 5′ primer sequence for the pET28a vector corresponds to 5′-cgtctcacatgtcttggtttctgattgcggtggcgactatcgc-3′ (translation start is underlined) and the 3′ primer sequence for the pET28a vector corresponds to 5′-cgagaagcttaatgatgatgatgcatatcg-3′ (translation stop is double underlined). The 5′ primer sequence for the pCWori vector corresponds to 5′-aagggaattccatatgtcttggtttctgattgcggtggcgactatcgc-3′ and the 3′ primer sequence for the pCWori vector corresponds to 5′-ctgctctagattaatgatgatgatgcatatcgtaaggcacgcggt-3′.
Expression conditions for CYP98A3
Expressions with the pET28a vector were performed in the E. coli BL21 strain and with the pCWori vector were performed in the E. coli DH5α strain. Expressions of His 4 CYP98A3 with the pCWori vector in BL21 (DE3) and XLBlue cells (both from Invitrogen) in rich media yielded lower P450 levels than obtained in DH5α cells.
Expressions in complete TB media were performed by inoculating 10 mL of a fresh overnight bacterial culture grown in TB containing 50 mg/L ampicillin into 1000 mL of TB (also containing ampicillin) in a 2.5 L Fernbach flask. The culture was incubated at 37°C with shaking at 200 rpm in a New Brunswick G-25 orbital shaker. When the OD 600 of the culture reached 0.8, expression was induced by adding isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM. The heme precursor δ-aminolevulinic (ALA) was also added to a final concentration of 0.5 mM. The rate of shaking was then reduced to 180 rpm and the temperature was lowered to 28°C. After an additional 24 h of incubation, the cells were harvested by centrifuging at 3000×g for 10 min at 4°C. When the GroES-GroEL chaperones were co-expressed, the media was supplemented with an additional 20 mg/L of chloramphenicol for selection/retention of the chaperone plasmids. Chaperone expression was induced at the same time as P450 expression by adding 4 g/L of L-arabinose for the pGro7 plasmid or 5 μg/L of tetracycline for the pGKJE8 plasmid.
Expressions in M9 labeling media were performed by inoculating 10 mL of a fresh overnight bacterial culture grown in LB containing 50 mg/L ampicillin into 1000 mL of LB (containing ampicillin) in a 2.5 L Fernbach flask. The culture was incubated at 37°C with shaking at 200 rpm in a New Brunswick G-25 orbital shaker. When the OD 600 reached 0.7, cells were pelleted by centrifuging for 30 min at 5000×g. The cell pellets were then washed once with 250 mL of M9 salts solution and repelleted as above. The cells were then gently resuspended in a volume of M9 minimal media equivalent to one fourth of the original LB culture volume as originally described by Marley et al. [40] and allowed to recover for 1 h at 28°C with shaking at 180 rpm. Induction was then carried out with the conditions described above for induction in complete TB media. Cells were harvested after an additional 24 h growth at 28°C. When chaperones were coexpressed, an additional 20 mg/L chloramphenicol and either 4 g/L arabinose or 5 μg tetracycline were included in the media and expression was performed using the same conditions described above.
P450 extraction and purification
Cell lysis, protein extraction and purifications were carried out with slight modifications on the procedures described in Wester et al. [31] . In brief, the cells were harvested by centrifugation at 3000×g for 10 min at 4°C. The cells were then resuspended in 10% of the original culture volume using 20 mM potassium phosphate buffer (pH 7.4) containing 20% glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 10 mM β-mercaptoethanol. The cell suspension was then treated with 0.3 mg/mL lysozyme for 45 min with stirring at 4°C. After 45 min, an equal volume of ice cold water was added slowly and incubated for an additional 15 min. The spheroplasts were then pelleted by centrifugation at 5000×g for 10 min at 4°C and lysed by freezing in a liquid nitrogen bath. The frozen pellet was thawed on ice and resuspended in 20% of the original culture volume using lysis/equilibration buffer [500 mM potassium phosphate buffer (pH 7.4) containing 20% glycerol, 0.5 mM PMSF, 10 mM β-mercaptoethanol, 1% CHAPS]. The spheroplasts were disrupted by sonicating for three 45 s pulses with 60 s of cooling on ice in between. The lysate was then centrifuged at 7000×g for 10 min and the supernatant was centrifuged at 105,000×g for 90 min.
The resulting 200 mL supernatant was directly applied to a 2-3 mL Ni-NTA agarose affinity column (Qiagen) that had been pre-equilibrated with the lysis/ equilibration buffer. After applying the cell lysate, the resin was washed with five volumes of the lysis/equilibration buffer and two volumes of wash buffer [100 mM potassium phosphate buffer (pH 7.4) containing 100 mM NaCl, 20% glycerol, 1 mM PMSF, 10 mM β-mercaptoethanol]. The column was subsequently washed with five column volumes of wash buffer containing 50 mM glycine and then another five column volumes of wash buffer containing 10 mM histidine. And, finally the P450 was eluted with 10 mM potassium phosphate buffer (pH 7.4) containing 100 mM NaCl, 20% glycerol, 1 mM PMSF, 10 mM β-mercaptoethanol, 1% CHAPS, and 40 mM histidine.
This eluent was diluted 10-fold with 5 mM potassium phosphate buffer (pH 7.4) containing 20% glycerol, 1 mM PMSF, 1 mM ethylenedinitrilotetraacetic acid (EDTA), 0.2 mM DL-dithiothreitol (DTT) and 1% CHAPS and applied to a 30-mL CM-Sepharose ion exchange column (Amersham Biosciences, Piscataway, NJ). Prior to applying the sample, the resin was equilibrated with five resin volumes of 10 mM potassium phosphate buffer (pH 7.4) containing 20% glycerol, 1 mM PMSF, 1 mM EDTA, 0.2 mM DTT and 1% CHAPS. The CMSepharose resin was then washed with five volumes of the equilibration buffer omitting the CHAPS detergent. The P450 was eluted using 50 mM potassium phosphate buffer (pH 7.4) with 500 mM sodium chloride, 20% glycerol, 1 mM EDTA and 0.2 mM DTT.
Precipitation for SSNMR
For precipitation trials, the fractions from the CM-Sepharose ion exchange column containing P450 were pooled and concentrated using Centricon-30 concentrators (Millipore Billerica, MA) to 20 mg/mL P450, as assayed by carbon monoxide (CO) difference spectra [45] . This concentrated protein sample was used to examine a small range of precipitation conditions based on the crystallographic screening of CYP98A3 (S.G. Rupasinghe, M.A. Schuler and C. expressed in labeling media was precipitated using the above conditions and was compacted using ultracentrifugation at 100,000×g for 45 min in a Beckman TL-100 ultracentrifuge. The dense-packed brown pellet was transferred to a 3.2-mm standard diameter rotor (Varian, Palo Alto, CA) and rubber discs were placed at each end of the rotor to prevent sample dehydration. C spectrum. All data were acquired at − 50°C (nominal temperature measured at the output of the variable temperature stack) using 95 scfh variable temperature flow. Data acquired at 17.6 T utilized the low E-field BioMAS probe to reduce RF-induced sample heating. The actual sample temperature is 5-10°C higher due to frictional heating from spinning [46] . N triple resonance experiments. The MAS rate was 11.11 kHz. The direct dimension acquisition time was 23 ms, following a 0.9 ms tangent ramped 1 H to 13 C CP, one supercycle of SPC-5 3 mixing (0.54 ms) each for excitation and reconversion of double-quantum coherence. During the mixing period, ∼ 110 kHz continuous wave decoupling was employed; during evolution and acquisition, 70 kHz TPPM decoupling was employed. The indirect (doublequantum) 13 C dimension was digitized to 768 rows with a 15 μs dwell time (time proportional phase incrementation (TPPI) sampling) [51] . The 2D spectrum was signal averaged for 145 h at − 50°C (nominal temperature) using 90 scfh variable temperature flow. The actual sample temperature is 15-25°C higher due to frictional heating from spinning and dielectric heating from the RF pulses [46, 52] .
SSNMR spectroscopy
Results
The pCWori vector that contains the IPTG-inducible tac promoter has been used to successfully express a number of N-terminally truncated P450s at high yields in E. coli [31] . In complete TB media, our initial expressions of Arabidopsis CYP98A3 using this pCWori vector yielded 3 mg P450 protein per liter of culture media as defined by CO difference analysis (Table 2) . But, in M9 minimal media, this same construct failed to yield any detectable P450 in spite of the fact that the N-terminal codons had been optimized for E. coli. Use of the pET28a vector that contains the IPTGinducible bacteriophage T7 promoter has been used successfully to express soluble Synechocystis CYP120 in E. coli for structural analysis [53] . As for the pCWori construct, expression of full-length His 4 CYP98A3 in the pET28a vector produced high yields of P450 in complete media and no detectable P450 in M9 minimal media.
Since it had been shown that human CYP8A1 (prostaglandin synthase) and CYP3A7 protein expressions were elevated when co-expressed with molecular chaperones GroEL and GroES [54, 55] , His 4 CYP98A3 was expressed in the presence of these molecular chaperones under control of the arabinose-inducible araB promoter (pGro7 plasmid). With these co-expressed proteins, CYP98A3 expression driven by the tac promoter was significantly elevated in complete media (Table 2 ) and detectable for the first time in M9 minimal media. Using these plasmids, expression and arabinose induction conditions, the yield of His 4 CYP98A3 in minimal media was 4 mg/L.
Since it is possible that the arabinose used for induction with ara + strains could enter central metabolism thereby diluting isotope pools [56] , expression was also attempted with molecular chaperones under control of the tetracyclineinducible pzt-1 promoter. CYP98A3 expression in this coexpression system occurred at a slightly lower level in complete media than with the araB promoter system and at half the level obtained in minimal media (Table 2) . Nevertheless, this system yielded 4 mg of 13 C, 15 N-labeled His 4 CYP98A3, as determined by CO difference analysis of the crude cell lysate, from 2 L of isotopically-enriched minimal media. Purification of this sample as described in Materials and methods yielded CM-Sepaharose ion exchange fractions that were approximately 90% clean after pooling (and before concentrating) (Fig. 1) . The CO-bound difference spectrum displayed a single peak at 450 nm indicating that the purified protein was appropriately folded and stable (Fig. 1b) . These fractions were pooled, concentrated to 20 mg/mL and precipitated using conditions determined for precipitating unlabeled CYP98A3. A smaller 13 C, 15 N-labeled His 4 CYP98A3 sample precipitated under the same conditions generated an absorption peak at 450 nm with a small shoulder at 420 nm (Fig. 1c ) when redissolved and analyzed by CO-difference spectroscopy, indicating that the labeled protein does not unfold upon precipitation.
SSNMR analysis of His 4 CYP98A3 yielded spectra consistent with a uniformly 13 C, 15 N-labeled, folded and homogenous protein. The 13 C and 15 N CP-MAS spectra (Fig. 2 ) have integrated signal intensities consistent with 2.5-3.0 mg of 13 C, 15 N-labeled protein (based on instrument calibrations performed with standard proteins of known quantity [57] ). Integration of the 13 C CP-MAS spectrum (Table 3) by region reports signal patterns consistent with the expected number of signals in each spectral region. For example, aliphatic 13 C signals with directly-bonded protons (including Cα, Cβ and methyls) have a CP enhancement factor of about two, indicating that the sample is predominantly rigid along the protein backbone. Non-protonated 13 C sites have lower CP enhance- ment. The dispersion of aliphatic and carbonyl resonances is consistent with expectations for a folded protein, as discussed further in the context of the 2D experiments below. The 1D 15 N spectrum shows no individually resolved signals, as expected for a protein of this size. However, the amide chemical shift dispersion from ∼ 100 to ∼140 ppm arises from amino acid types in distinct secondary structures, indicative of a folded protein.
Characteristic resonances of individual amino acids in the protein are resolved in 2D spectra. For example, significant dispersion of chemical shifts in the 13 C-13 C correlation spectrum is derived from secondary shifts of Cα and Cβ sites, as well as conformation-dependent chemical shifts of side-chain resonances (Fig. 3) . The majority of the peak intensity reports α-helical Cα, Cβ and C' (backbone carbonyl) chemical shifts [58] . Smaller portions of the signals have shifts consistent with β-sheet or turn secondary structure. In addition to providing secondary structure information, the 13 C-13 C spectrum has, in the well-resolved regions of the spectrum, the expected number signals for a single structural conformation of His 4 CYP98A3. Illustrative of this, the region from 15 to 25 ppm in F1 and 170 to 185 in F2 includes only Ala Cβ-C' signals at the 10 ms mixing time used (Fig. 3b) . The polarization transfer dynamics under this condition of spinning and with the particular pulse sequence used on this instrument were calibrated with several model proteins, such as GB1. [57] Peak counts performed manually or by Sparky [59] yielded 35 signals in this region, close to the number of Ala residues (42) in His 4 CYP98A3. Likewise, peak counts of the Gly C'-Cα region of the spectrum (Fig. 3c) static heterogeneities in some parts of the protein. However, the line widths in general are 0.5 ppm or less, consistent with factors such as scalar 13 C-13 C couplings contributing a major part of the observed line width.
In addition to the residue types most easily identified in the broadband 13 C-13 C single quantum correlation spectrum (Gly, Ala, Ile), the Ser and Thr residues appear in unique regions of the spectrum, near the diagonal with downfield shifted Cβ signals. Ser and Thr residues in helical conformations have similar Cα and Cβ chemical shifts and, therefore, may be hard to distinguish from the diagonal intensity. To partially remedy this situation we performed a 2D 13 C-13 C INADEQUATE correlation experiment (Fig. 4) . The spectrum avoids autocorrelated peaks by virtue of a double-quantum filter and the selected double-quantum excitation and reconversion time (using SPC-5) [60] ensures that only one-bond correlations appear with significant intensity. These features make the spectrum ideal to view the near diagonal α-helical Ser and Thr Cα-Cβ correlations (Fig. 4a) and ascertain the distribution of secondary structure. Likewise, the INADEQUATE spectrum amplifies the dispersion of Gly C'-Cα correlations that have a large dispersion among secondary structure elements (Fig. 4b) , many of which are uniquely resolved even at the relatively low spectrometer frequency of 500 MHz. This is due to the Cα and C' chemical shifts both increasing when the residue in an α-helix and decreasing when found in a β-sheet structure. This difference is magnified in the F1 dimension where the ω1 and ω2 frequencies are added. Integration of the Gly C'-Ca regions shows that 57% of the Gly residues are in α-helices, 31% in a turn conformation and 12% of the Gly in β-sheets.
Discussion
We have developed improved protocols for expression and purification of isotopically labeled P450 monooxygenases, enabling preparation of uniformly 13 C, 15 N-labeled samples in sufficient quantities to perform 2D MAS SSNMR experiments. Expression conditions were optimized based upon co-expression of chaperones, adjustment of incubation temperature and aeration parameters, and formulation of media according protocols by Marley et al. [40] . His 4 CYP98A3 was prepared in sufficiently high purity with CO binding assays demonstrating that the majority of the material was in the appropriately folded form. Precipitation of the protein by low molecular weight PEG yielded essentially quantitative yields of microscopically wellordered samples for SSNMR.
SSNMR 2D chemical shift correlation spectra of His 4 CYP98A3 show that the protein is folded in a single structural conformation, based upon observations of approximately the correct number of Gly, Ala and Ile spin systems. Although some signals may have depressed intensities and, therefore, be under the threshold for detection in these spectra, the majority of sites are observed. Signal intensities and enhancement factors by CP are in agreement with other proteins (microcrystalline, membrane or fibrous) studied in our laboratories. Thus the sample is microscopically well ordered, with linewidths of approximately 0.5 ppm, and shows all evidence of a folded tertiary structure, based upon biophysical characterization, optical spectroscopic signatures, as well as SSNMR spectroscopy. Over 3-4 weeks of NMR acquisition, the sample retained its native structure as evidenced by the unchanged 13 C-CP 1D appearance.
In this analysis, His 4 CYP98A3 is a full-length membrane protein (58.3 kDa in its native form) prepared as a macroscopic precipitate by PEG precipitation, a method similar to the manner in which crystals of truncated, soluble forms of eukaryotic P450s are often prepared for crystallographic studies. Consequently, the SSNMR spectra of this full-length protein can be compared directly to crystallographic studies of mammalian P450 monooxygenases lacking only their Nterminal signal anchor sequence. Since single crystals are not required for SSNMR, a significantly larger range of conditions and substrate-bound forms can be examined. Additionally, the incorporation of CYP98A3 into nanoscale discoidal lipid bilayers (Nanodiscs) [61] [62] [63] [64] can enable studies of the conformational effects of substrate binding and/or varying associations with lipid bilayers.
Despite the large size of this protein, the fact that the 2D spectra have sufficient sensitivity and resolution with only a few days of acquisition demonstrates that SSNMR has the potential to provide structural and mechanistic information for P450 monooxygenases that may not be amenable to crystallographic study or correctly folded under conditions suitable for single crystal growth. To perform complete chemical shift assignments and determine de novo structures from the SSNMR spectra alone will require application of more timeconsuming 3D experiments. With the samples as prepared, such 3D experiments would require approximately 7 to 10 day acquisition times. The development of high-yield expression protocols now enables larger quantities of materials to be prepared for this analysis. This capability, in combination with advances in SSNMR methodology, promises to permit more complete analyses of structural data in this important class of membrane-associated proteins. Thus, the current study represents an important advance, enabling the preparation of large quantities of isotopically labeled P450 monooxygenases, which will be applicable to a range of similar proteins for SSNMR studies.
